Michela Buccioni

2.8k total citations · 1 hit paper
102 papers, 2.2k citations indexed

About

Michela Buccioni is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michela Buccioni has authored 102 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 49 papers in Physiology and 33 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michela Buccioni's work include Receptor Mechanisms and Signaling (50 papers), Adenosine and Purinergic Signaling (49 papers) and Pharmacological Receptor Mechanisms and Effects (27 papers). Michela Buccioni is often cited by papers focused on Receptor Mechanisms and Signaling (50 papers), Adenosine and Purinergic Signaling (49 papers) and Pharmacological Receptor Mechanisms and Effects (27 papers). Michela Buccioni collaborates with scholars based in Italy, Germany and United States. Michela Buccioni's co-authors include Gabriella Marucci, Rosaria Volpini, Diego Dal Ben, Catia Lambertucci, Francesco Amenta, Ajiroghene Thomas, Gloria Cristalli, Andrea Spinaci, Karl‐Norbert Klotz and Filippo Maggi and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Michela Buccioni

99 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

2020 736 citations Gabriella Marucci, Michela Buccioni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michela Buccioni Italy	23	1.0k	557	496	456	325	102	2.2k
Gabriella Marucci Italy	27	1.4k 1.4×	828 1.5×	563 1.1×	582 1.3×	488 1.5×	147	2.7k
Catia Lambertucci Italy	29	1.5k 1.5×	761 1.4×	1.2k 2.4×	483 1.1×	397 1.2×	113	3.0k
Cornelis J. Van der Schyf United States	34	1.1k 1.1×	716 1.3×	180 0.4×	571 1.3×	629 1.9×	87	2.9k
Rosaria Volpini Italy	34	2.1k 2.1×	1.1k 1.9×	1.9k 3.9×	500 1.1×	590 1.8×	164	4.1k
Ramón Soto‐Otero Spain	29	801 0.8×	518 0.9×	71 0.1×	622 1.4×	516 1.6×	61	2.5k
Barbara Filipek Poland	29	981 1.0×	911 1.6×	92 0.2×	363 0.8×	628 1.9×	167	2.7k
Angeliki P. Kourounakis Greece	29	894 0.9×	852 1.5×	176 0.4×	303 0.7×	173 0.5×	69	2.1k
Fabiana Morroni Italy	28	955 0.9×	376 0.7×	63 0.1×	386 0.8×	152 0.5×	44	2.1k
Estefanı́a Méndez-Álvarez Spain	26	664 0.7×	480 0.9×	51 0.1×	531 1.2×	399 1.2×	53	2.1k
Clementina Manera Italy	30	970 1.0×	773 1.4×	129 0.3×	1.0k 2.2×	540 1.7×	135	2.6k

Countries citing papers authored by Michela Buccioni

Since Specialization

Citations

This map shows the geographic impact of Michela Buccioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Buccioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Buccioni more than expected).

Fields of papers citing papers by Michela Buccioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Buccioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Buccioni. The network helps show where Michela Buccioni may publish in the future.

Co-authorship network of co-authors of Michela Buccioni

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Buccioni. A scholar is included among the top collaborators of Michela Buccioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Buccioni. Michela Buccioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spinaci, Andrea, Michela Buccioni, Diego Dal Ben, et al.. (2025). A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease. Cells. 14(5). 338–338. 1 indexed citations

Ben, Diego Dal, Michela Buccioni, Catia Lambertucci, et al.. (2025). Radioligands Targeting the Purinergic P2X Receptors. Cells. 14(13). 984–984. 1 indexed citations

Murugesan, Akshaya, Michela Buccioni, Chang Cui, et al.. (2025). A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment. European Journal of Pharmaceutical Sciences. 207. 107039–107039. 2 indexed citations

Murugesan, Akshaya, Konda Mani Saravanan, Gabriella Marucci, et al.. (2025). Comparative analysis of the antiglioblastoma activity of adenosine A2A receptor and CK1δ blockers. European Journal of Pharmacology. 1002. 177864–177864.

Venugopala, Katharigatta N. & Michela Buccioni. (2024). Current Understanding of the Role of Adenosine Receptors in Cancer. Molecules. 29(15). 3501–3501. 5 indexed citations

Spinaci, Andrea, Catia Lambertucci, Chang Cui, et al.. (2024). Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme. Medicinal Chemistry Research. 33(4). 611–619.

Spinaci, Andrea, Michela Buccioni, Daniela Catarzi, et al.. (2023). “Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals. 16(2). 167–167. 9 indexed citations

Angeloni, Simone, Diego Dal Ben, Catia Lambertucci, et al.. (2023). Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders. Molecules. 28(12). 4762–4762. 1 indexed citations

Spinaci, Andrea, Michela Buccioni, Diego Dal Ben, et al.. (2022). A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity. Pharmaceuticals. 15(2). 164–164. 4 indexed citations

10.

Spinaci, Andrea, Catia Lambertucci, Michela Buccioni, et al.. (2022). A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?. Molecules. 27(8). 2386–2386. 7 indexed citations

11.

Varano, Flavia, Daniela Catarzi, Diego Dal Ben, et al.. (2021). Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression. Pharmaceuticals. 14(7). 657–657. 5 indexed citations

12.

Nzekoue, Franks Kamgang, Giovanni Caprioli, Dennis Fiorini, et al.. (2020). Butter oil (ghee) enrichment with aromatic plants: Chemical characterization and effects on fibroblast migration in anin-vitro wound healing model. Arabian Journal of Chemistry. 13(12). 8909–8919. 11 indexed citations

13.

Falsini, Matteo, Daniela Catarzi, Flavia Varano, et al.. (2020). New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 30(11). 127126–127126. 5 indexed citations

14.

Falsini, Matteo, Daniela Catarzi, Flavia Varano, et al.. (2019). Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A_2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain. Journal of Medicinal Chemistry. 62(18). 8511–8531. 14 indexed citations

15.

Falsini, Matteo, Daniela Catarzi, Flavia Varano, et al.. (2019). Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells. Bioorganic Chemistry. 87. 380–394. 12 indexed citations

16.

Ben, Diego Dal, Catia Lambertucci, Michela Buccioni, et al.. (2019). Non-Nucleoside Agonists of the Adenosine Receptors: An Overview. Pharmaceuticals. 12(4). 150–150. 11 indexed citations

17.

Varano, Flavia, Daniela Catarzi, Matteo Falsini, et al.. (2018). Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity. Bioorganic & Medicinal Chemistry Letters. 29(4). 563–569. 10 indexed citations

18.

Marucci, Gabriella, Michela Buccioni, Catia Lambertucci, et al.. (2018). Anticancer activity study of A 3 adenosine receptor agonists. Life Sciences. 205. 155–163. 13 indexed citations

19.

Lambertucci, Catia, Michela Buccioni, Diego Dal Ben, et al.. (2015). New substituted 9-propyladenine derivatives as A_2Aadenosine receptor antagonists. MedChemComm. 6(5). 963–970. 9 indexed citations

20.

Franchini, Silvia, Annalisa Tait, Claudia Sorbi, et al.. (2008). (2,2‐Diphenyl‐[1,3]oxathiolan‐5‐ylmethyl)‐(3‐phenyl‐propyl)‐amine: a Potent and Selective 5‐HT_1A Receptor Agonist. ChemMedChem. 4(2). 196–203. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact